Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Sonam Dilwali, MD, PhD

Title(s)Resident, Neurology
SchoolSchool of Medicine
Phone415-353-2273
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shah DR, Dilwali S, Friedman DI. Correction to: Migraine Aura Without Headache. Curr Pain Headache Rep. 2018 10 20; 22(12):85. PMID: 30343336.
      View in: PubMed
    2. Shah DR, Dilwali S, Friedman DI. Migraine Aura Without Headache [corrected]. Curr Pain Headache Rep. 2018 09 17; 22(11):77. PMID: 30225597.
      View in: PubMed
    3. Landegger LD, Sagers JE, Dilwali S, Fujita T, Sahin MI, Stankovic KM. A Unified Methodological Framework for Vestibular Schwannoma Research. J Vis Exp. 2017 06 20; (124). PMID: 28654042.
      View in: PubMed
    4. Landegger LD, Dilwali S, Stankovic KM. Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research. J Vis Exp. 2017 06 08; (124). PMID: 28654047.
      View in: PubMed
    5. Soares VY, Atai NA, Fujita T, Dilwali S, Sivaraman S, Landegger LD, Hochberg FH, Oliveira CA, Bahmad F, Breakefield XO, Stankovic KM. Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells. Neuro Oncol. 2016 11; 18(11):1498-1507. PMID: 27194145.
      View in: PubMed
    6. Dilwali S, Landegger LD, Soares VY, Deschler DG, Stankovic KM. Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage. Sci Rep. 2015 Dec 22; 5:18599. PMID: 26690506.
      View in: PubMed
    7. Dilwali S, Briët MC, Kao SY, Fujita T, Landegger LD, Platt MP, Stankovic KM. Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth. Mol Oncol. 2015 Aug; 9(7):1359-70. PMID: 25891780.
      View in: PubMed
    8. Dilwali S, Kao SY, Fujita T, Landegger LD, Stankovic KM. Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res. 2015 Jul; 166(1):1-11. PMID: 25616959.
      View in: PubMed
    9. Dilwali S, Roberts D, Stankovic KM. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells. Cancer Biol Ther. 2015; 16(1):170-5. PMID: 25692621.
      View in: PubMed
    10. Dilwali S, Patel PB, Roberts DS, Basinsky GM, Harris GJ, Emerick KS, Stankovic KM. Primary culture of human Schwann and schwannoma cells: improved and simplified protocol. Hear Res. 2014 Sep; 315:25-33. PMID: 24910344.
      View in: PubMed
    11. Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM. Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol. 2014 Feb; 35(2):353-7. PMID: 24448296.
      View in: PubMed
    12. Platt M, Dilwali S, Elackattu A, Parikh JR, Stankovic KM. Mining immune epitopes in the inner ear. Otolaryngol Head Neck Surg. 2014 Mar; 150(3):460-3. PMID: 24367049.
      View in: PubMed
    13. Dilwali S, Lysaght A, Roberts D, Barker FG, McKenna MJ, Stankovic KM. Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size. Otol Neurotol. 2013 Jun; 34(4):748-54. PMID: 23512073.
      View in: PubMed